Search

Your search keyword '"Nicoletti, F."' showing total 127 results

Search Constraints

Start Over You searched for: Author "Nicoletti, F." Remove constraint Author: "Nicoletti, F." Publisher elsevier bv Remove constraint Publisher: elsevier bv
127 results on '"Nicoletti, F."'

Search Results

2. Pharmacokinetic interactions between esketamine and different classes of antidepressants in patients with treatment-resistant depression

3. The bacterial quorum sensing molecule, 2-heptyl-3-hydroxy-4-quinolone (PQS), inhibits signal transduction mechanisms in brain tissue and is behaviorally active in mice

5. The reduction in glutamate release is predictive of cognitive and emotional alterations that are corrected by the positive modulator of AMPA receptors S 47445 in perinatal stressed rats

21. Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG/Rij rats

23. Electrophysiological and metabolic effects of CHF5074 in the hippocampus: Protection against in vitro ischemia

26. Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats

31. Impact of early life stress on alcohol consumption and on the short- and long-term responses to alcohol in adolescent female rats

32. Protective role for type-1 metabotropic glutamate receptors against spike and wave discharges in the WAG/Rij rat model of absence epilepsy

34. The origin recognition complex subunit, ORC3, is developmentally regulated and supports the expression of biochemical markers of neuronal maturation in cultured cerebellar granule cells

35. Enhanced expression of the neuronal K+/Cl− cotransporter, KCC2, in spontaneously depressed Flinders Sensitive Line rats

37. Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis

38. Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells

43. Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis

45. Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies

47. C21. GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG

Catalog

Books, media, physical & digital resources